As of 2025-06-16, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -22.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,683.59 mil USD. TNDM's TTM EBITDA according to its financial statements is -75.07 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 11.0x | 9.2x |
| Forward P/E multiples | 13.0x - 20.6x | 16.3x |
| Fair Price | (19.17) - (16.93) | (18.88) |
| Upside | -192.3% - -181.6% | -191.0% |
| Date | EV/EBITDA |
| 2025-06-13 | -22.43 |
| 2025-06-12 | -22.57 |
| 2025-06-11 | -23.13 |
| 2025-06-10 | -23.92 |
| 2025-06-09 | -21.96 |
| 2025-06-06 | -22.45 |
| 2025-06-05 | -22.34 |
| 2025-06-04 | -21.91 |
| 2025-06-03 | -22.31 |
| 2025-06-02 | -21.95 |
| 2025-05-30 | -21.59 |
| 2025-05-29 | -22.89 |
| 2025-05-28 | -22.77 |
| 2025-05-27 | -23.07 |
| 2025-05-23 | -22.39 |
| 2025-05-22 | -22.32 |
| 2025-05-21 | -23.22 |
| 2025-05-20 | -24.88 |
| 2025-05-19 | -24.18 |
| 2025-05-16 | -24.49 |
| 2025-05-15 | -24.15 |
| 2025-05-14 | -24.28 |
| 2025-05-13 | -24.53 |
| 2025-05-12 | -24.81 |
| 2025-05-09 | -24.40 |
| 2025-05-08 | -24.18 |
| 2025-05-07 | -23.76 |
| 2025-05-06 | -22.92 |
| 2025-05-05 | -22.90 |
| 2025-05-02 | -23.07 |
| 2025-05-01 | -21.74 |
| 2025-04-30 | -18.96 |
| 2025-04-29 | -18.89 |
| 2025-04-28 | -19.51 |
| 2025-04-25 | -20.03 |
| 2025-04-24 | -19.69 |
| 2025-04-23 | -18.71 |
| 2025-04-22 | -18.51 |
| 2025-04-21 | -18.55 |
| 2025-04-17 | -18.97 |
| 2025-04-16 | -19.32 |
| 2025-04-15 | -19.72 |
| 2025-04-14 | -19.12 |
| 2025-04-11 | -19.14 |
| 2025-04-10 | -19.13 |
| 2025-04-09 | -19.63 |
| 2025-04-08 | -18.53 |
| 2025-04-07 | -18.96 |
| 2025-04-04 | -18.98 |
| 2025-04-03 | -19.68 |